4.5 Article

Meningococcal Disease in the Post-COVID-19 Era: A Time to Prepare

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Health Care Sciences & Services

Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011-30

Salin Sriudomporn et al.

Summary: We estimated the costs, financing, and funding gaps for 16 vaccines in 94 low- and middle-income countries from 2011 to 2030. The main driver of the funding gap was the cost of immunization delivery, resulting in a total funding gap of $38.4 billion. While government financing of vaccination programs increases over time, the decline in both Gavi and development assistance for health financing exceeds the forecasted increases in domestic government spending on immunization.

HEALTH AFFAIRS (2023)

Editorial Material Infectious Diseases

Quantifying the RSV immunity debt following COVID-19: a public health matter

Marie-Noelle Billard et al.

LANCET INFECTIOUS DISEASES (2023)

Review Infectious Diseases

Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review

Mark R. Alderson et al.

Summary: This review article summarizes information regarding global meningococcal infection, including the impact of COVID-19 on its prevalence and vaccine compliance, as well as the antibiotic resistance of Neisseria meningitidis. The article also highlights the progress made in the development of meningococcal vaccines.

JOURNAL OF INFECTION (2022)

Article Public, Environmental & Occupational Health

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations

Federico Martinon-Torres et al.

Summary: Invasive meningococcal disease (IMD) is a serious and unpredictable condition that can be prevented through vaccination. Different countries have varied vaccination strategies, with most focusing on vaccination in infants and adolescents. The introduction of routine meningococcal vaccinations has led to a gradual reduction in IMD incidence in Europe since 1999.

PATHOGENS AND GLOBAL HEALTH (2022)

Article Pediatrics

Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study

Helen Campbell et al.

Summary: The adolescent immunisation programme targeting meningococcal disease in the UK successfully controlled a national MenW outbreak, particularly among adolescent carriers, even with moderate initial vaccine uptake.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Article Infectious Diseases

Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease

Stefan Scholz et al.

Summary: This study assessed the potential public health and economic impact of introducing routine 4CMenB infant vaccination in Germany to prevent invasive meningococcal disease (IMD) caused by serogroup B. The model predicted a rapid decline in disease cases and deaths in infants and young children aged 0-4 years after vaccination.

INFECTIOUS DISEASES AND THERAPY (2022)

Article Immunology

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study

Milou Ohm et al.

Summary: The MenACWY vaccination program in the Netherlands effectively prevented invasive meningococcal W disease in the target population during an epidemic. Following the implementation of MenACWY vaccination, the incidence rate of IMD-W decreased by 61%, with significant reductions seen in vaccine-eligible age groups.

CLINICAL INFECTIOUS DISEASES (2022)

Review Public, Environmental & Occupational Health

Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review

Jing Shen et al.

Summary: This study comprehensively characterizes the sequelae of invasive meningococcal disease (IMD) and identifies the physical/neurological sequelae relevant to economic evaluation. The study found that the burden of IMD sequelae on survivors and their families is potentially underestimated in economic evaluations, due to underreporting and poorly-defined sequelae.

BMC PUBLIC HEALTH (2022)

Article Economics

Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward

Eleanor Bell et al.

Summary: The study highlights the gap in recognizing the broader value of vaccines within Health Technology Assessment processes in higher-income countries. Experts identified five priority areas for broader value recognition and recommended a three-pronged approach to proactively steer generation of high-quality evidence, leverage existing expertise, and stimulate stakeholder engagement for more comprehensive value assessment processes globally.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2022)

Article Immunology

Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California

Chun R. Chao et al.

Summary: This study evaluated the trends of HPV vaccination between March 2019 and September 2021 and assessed whether the impact of the COVID-19 pandemic on HPV vaccination varied by race/ethnicity and neighborhood deprivation index. The results showed that HPV vaccine doses administered in 2020/2021 have returned to the 2019 level after an initial drop. However, the average up-to-date coverage in May 2021 to September 2021 remained lower than the pre-pandemic level. Additionally, the associations between race/ethnicity, neighborhood deprivation index, and HPV vaccine coverage did not vary due to the pandemic.

VACCINE (2022)

Article Immunology

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England

Marta Bertran et al.

Summary: In England, after the removal of COVID-19 restrictions in July-December 2021, the incidence of invasive pneumococcal disease in children under 15 years old was higher compared to the same period in 2020 and the pre-pandemic years of 2017-2019. This highlights the potential risk following the relaxation of COVID-19 restrictions, emphasizing the need to maintain childhood vaccine coverage to protect the population.

EMERGING INFECTIOUS DISEASES (2022)

Review Immunology

Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada

Liping Huang et al.

Summary: The evolution of meningococcal vaccine recommendations in the UK, US, the Netherlands, and Canada was influenced by changes in vaccine availability and serogroup incidence, as well as public pressure due to the catastrophic nature of invasive meningococcal disease (IMD). The role of cost-effectiveness analyses varied across the four countries.

EXPERT REVIEW OF VACCINES (2021)

Article Immunology

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020

Marit Middeldorp et al.

Summary: After the implementation of Dutch COVID-19 response measures, the incidence of various VPDs decreased by 75-97%, while participation in the measles-mumps-rubella vaccination among children dropped initially by 6-14% with a remaining difference of -1% to -2% after catch-up vaccination. The pandemic has reduced the incidence of several VPDs with limited impact on routine infant vaccination programme.

VACCINE (2021)

Article Immunology

Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination

Altacilio Aparecido Nunes et al.

Summary: Introduction of MenC vaccination in Brazil led to significant reductions in both the incidence and mortality rates of meningococcal disease, especially among children under 5 years of age, largely driven by the decrease in the MenC serogroup. Despite these considerable benefits, the prevalence of MD due to other serogroups such as MenW and MenB remains a concern.

VACCINE (2021)

Article Economics

Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease

Ekkehard Beck et al.

Summary: This cost-effectiveness analysis in England of 4CMenB infant vaccination comprehensively considers the burden of MenB invasive meningococcal disease, demonstrating that 4CMenB infant vaccination can be cost-effective when the burden of MenB IMD is comprehensively considered.

VALUE IN HEALTH (2021)

Article Immunology

Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents

Mark McMillan et al.

Summary: The study in South Australia showed that vaccinating adolescents with 4CMenB was associated with a significant reduction in serogroup B invasive meningococcal disease cases, indicating the effectiveness of the vaccine in preventing meningococcal disease in adolescents.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Defeating meningitis by 2030: the WHO roadmap

Priya Venkatesan

LANCET INFECTIOUS DISEASES (2021)

Editorial Material Medicine, General & Internal

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

J. Peter Figueroa et al.

LANCET (2021)

Article Multidisciplinary Sciences

Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea

Heun Choi et al.

Summary: University students, especially those living in dormitories, have a high risk of invasive meningococcal disease, with carriage rates increasing significantly within the first 3 months of dormitory stay. Male sex and frequent visits to pubs or clubs were significantly associated with meningococcal carriage. In addition, six carriers were found to transmit meningococci to other study participants based on serotype and MLST analyses.

PLOS ONE (2021)

Review Microbiology

A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control

Yih-Ling Tzeng et al.

Summary: Neisseria meningitidis, a common pathogen, can be divided into different groups based on capsular polysaccharide structures, and there have been changes in the capsular groups causing invasive meningococcal disease in modern society. The spread and transmission of Neisseria meningitidis are influenced by vaccinations, drug treatments, and disease evolution.

MICROORGANISMS (2021)

Article Biotechnology & Applied Microbiology

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile

Maria Gabriela Grana et al.

Summary: The study evaluated the impact of different vaccination strategies for preventing invasive meningococcal disease in Chile using a model. It found that combining infant 4CMenB vaccination with toddler and adolescent MenACWY vaccination had the greatest benefits in reducing IMD cases across all age groups.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Letter Pediatrics

Respiratory syncytial virus: paying the immunity debt with interest

Lee Hatter et al.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Review Immunology

Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review

Ifechukwu B. Nwogu et al.

Summary: The cost-effectiveness of MenB vaccination has been reviewed, showing that none of the vaccination strategies are considered cost-effective. Adolescent vaccination strategies offer the best value for money, although routine infant vaccination was found to be the most effective short-term strategy. The lack of substantial value for money is mainly attributed to high vaccine costs and low disease incidence.

VACCINE (2021)

Article Public, Environmental & Occupational Health

The Societal Value of Vaccination in the Age of COVID-19

David E. Bloom et al.

Summary: Recently, scholars and policymakers have started to realize that the value of vaccines extends beyond health benefits to encompass economic and social welfare. The COVID-19 pandemic has highlighted the significant harms infectious diseases can inflict on society, potentially leading policymakers to take into account the broader societal impacts of vaccination.

AMERICAN JOURNAL OF PUBLIC HEALTH (2021)

Article Pediatrics

Impact of COVID-19 social distancing on viral infection in France: A delayed outbreak of RSV

Celine Delestrain et al.

Summary: The RSV epidemic in the 2020-2021 season in France started 12 weeks later in the Ile de France region compared to previous seasons, and gradually spread across all the metropolitan regions in France. The peak number of bronchiolitis cases in 2021 occurred at week 12, 10-12 weeks after the previous seasonal peaks, but the number of cases remained lower than in previous seasonal peaks.

PEDIATRIC PULMONOLOGY (2021)

Editorial Material Pediatrics

Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic

Rabia Agha et al.

PEDIATRICS (2021)

Article Public, Environmental & Occupational Health

Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021

Sonja J. Olsen et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Public, Environmental & Occupational Health

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020

Cassandra Pingali et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Pediatrics

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020

Marion Taine et al.

Summary: During the first lockdown in France, there were significant decreases in the dispensation of both priming doses and boosters for infants, particularly for MMR priming doses and Men-C-C boosters. Although vaccination counts slightly increased after the lockdown, they remained below the expected numbers.

FRONTIERS IN PEDIATRICS (2021)

Review Infectious Diseases

Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination

Lamine Soumahoro et al.

Summary: The study reviewed literature on outbreak response strategies and vaccine interventions for IMD from 1997-2020, finding that emergency vaccination responses incurred substantial costs and faced impediments such as limited information transmission to parents/communities/healthcare workers, issues with informed consents, and poor vaccine uptake by specific age groups.

INFECTIOUS DISEASES AND THERAPY (2021)

Review Infectious Diseases

Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?

Robert Cohen et al.

Summary: The COVID-19 pandemic has reduced the incidence of many viral and bacterial infections in children, leading to a positive short-term effect of preventing healthcare system overload. However, the reduced exposure to pathogens and vaccination rates may result in a potential immunity debt and increase the risk of future epidemics when non-pharmaceutical interventions are lifted.

INFECTIOUS DISEASES NOW (2021)

Article Mathematics, Applied

MULTIPLE POSITIVE SOLUTIONS FOR NONHOMOGENEOUS SCHRODINGER-POISSON SYSTEMS WITH BERESTYCKI-LIONS TYPE CONDITIONS

Lan-Xin Huang et al.

Summary: In this article, we investigate the multiplicity of solutions for non-homogeneous Schrodinger-Poisson systems under certain conditions. Using Ekeland's variational principle, the mountain pass theorem, and a Pohozaev type identity, we prove that the system has at least two positive solutions.

ELECTRONIC JOURNAL OF DIFFERENTIAL EQUATIONS (2021)

News Item Infectious Diseases

Learning from a massive epidemic: measles in DRC

Tanja Ducomble et al.

LANCET INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020

Jeanne M. Santoli et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Health Care Sciences & Services

COVID-19 and Underinvestment in the Public Health Infrastructure of the United States

Nason Maani et al.

MILBANK QUARTERLY (2020)

Article Economics

Economic evaluation of meningococcal vaccines: considerations for the future

Hannah Christensen et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2020)

Article Public, Environmental & Occupational Health

Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors

S. Watle et al.

EPIDEMIOLOGY AND INFECTION (2020)

Review Biotechnology & Applied Microbiology

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination

Cynthia Burman et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Article Biotechnology & Applied Microbiology

B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia

Mark McMillan et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Review Economics

Costs of Invasive Meningococcal Disease: A Global Systematic Review

Bing Wang et al.

PHARMACOECONOMICS (2018)

Editorial Material Cell Biology

The broad socioeconomic benefits of vaccination

David E. Bloom et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Infectious Diseases

Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data

Caroline L. Trotter et al.

LANCET INFECTIOUS DISEASES (2017)

Article Immunology

Estimating the full public health value of vaccination

Bradford D. Gessner et al.

VACCINE (2017)

Editorial Material Immunology

Moving beyond traditional valuation of vaccination: Needs and opportunities

David E. Bloom et al.

VACCINE (2017)

Review Psychology, Developmental

Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements

Federico Martinon-Torres

JOURNAL OF ADOLESCENT HEALTH (2016)

Review Clinical Neurology

Invasive Meningococcal Disease in the 21st Century-An Update for the Clinician

Rachel Dwilow et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)

Article Immunology

Antigenic shift and increased incidence of meningococcal disease

LH Harrison et al.

JOURNAL OF INFECTIOUS DISEASES (2006)

Article Medicine, General & Internal

Clinical recognition of meningococcal disease in children and adolescents

MJ Thompson et al.

LANCET (2006)